相关实验视频
Updated: Jan 18, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.2K
喘-OSA重叠综合征:一个独特的内分类型?
Antonio Fabozzi1, Izolde Bouloukaki2, Matteo Bonini1
1Department of Public Health and Infectious Diseases, Pulmonology Unit, Policlinico Umberto I, "Sapienza" University of Rome, 00185, Rome, Italy.
Respiratory medicine
|September 7, 2025
概括
另类重叠综合征 (aOVS),喘和阻塞性睡眠呼吸暂停 (OSA) 的共存,是低诊断的. 识别aOVS作为一个独特的内分类型对于个性化喘和OSA管理至关重要.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 睡眠医学 睡眠医学
- 免疫学 免疫学 免疫学
背景情况:
- 喘和阻塞性睡眠呼吸暂停 (OSA) 经常同时存在,形成替代重叠综合征 (aOVS).
- 这种疾病往往被低估和诊断不足,尽管有共同的危险因素,如肥胖,GERD和鼻炎.
- aOVS具有独特的病理生理特征,包括低兴奋值,夜间支气管过敏反应和自主功能障碍.
研究的目的:
- 审查目前关于aOVS的证据,涵盖其病理生理学,临床,功能和治疗方面.
- 评估aOVS是否代表一个独特的内分类型,需要量身定制的诊断和治疗方法.
- 突出识别aOVS对于改善患者治疗结果的重要性.
主要方法:
- 对喘和OSA研究的综合文献综述重叠.
- 分析喘和OSA之间的病理生理机制.
- 评估来自aOVS患者的临床,功能和治疗数据.
主要成果:
- 与单个病症患者相比,aOVS患者表现出降低的FEV1和增加的夜间低氧症.
- 这种综合症与喘控制较差,恶化更频繁,生活质量下降有关.
- 持续的正气道压力 (CPAP) 治疗改善了喘控制,症状负担和炎症.
结论:
- aOVS应该被认为是一种独特的临床内分类型.
- 及时识别和个性化管理策略对于改善患者护理至关重要.
- 需要进一步的研究来了解长期的结果,并优化针对aOVS的个性化疗法.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K

